Bolus fibrinolytic therapy in acute myocardial infarction.
about
Cloning and Expression of Functional Reteplase in Escherichia coli TOP10.A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase.Serum levels of thrombotic markers in patients with acute myocardial infarction.Cardiorespiratory physical assessment for the acutely ill: 2.Safety and efficacy of tenecteplase in acute myocardial infarction.Low-molecular-weight heparin in patients with acute ST-segment elevation myocardial infarction.Understanding the enzymology of fibrinolysis and improving thrombolytic therapy.Intracranial haemorrhage 4 days after receiving thrombolytic therapy in a young woman with myocardial infarction.Cost-Effectiveness of Thrombolytic Therapy, Compared with Anticoagulants Therapy in the Treatment of Acute Myocardial Infarction in Albania.Fibrinolytic agents for the management of ST-segment elevation myocardial infarction.Role of thrombolysis in reperfusion therapy for management of AMI: Indian scenarioTranslational initiatives in thrombolytic therapy.Optimization of the expression of reteplase in Escherichia coli.Systemic or Endoventricular Thrombolysis to Treat HeartWare Left Ventricle Assist Device Thrombosis: A Clinical Dilemma.ST-segment-elevation myocardial infarction: guidelines and the challenge of real-world patient care.Comparison of clot lysis activity and biochemical properties of originator tenecteplase (Metalyse(®)) with those of an alleged biosimilarTissue plasminogen activator deficiency promotes early phase regeneration in the olfactory epithelium after bulbectomy.Morphological assessment of the luminal surface of olfactory epithelium in mice deficient in tissue plasminogen activator following bulbectomy.
P2860
Q30352632-205F3F56-4890-42EA-98FC-2E21544A3842Q30388279-38B82E36-4D6E-4A3E-AF49-15D4C8AE62A9Q33756326-90BE4D73-C44F-489A-9B2F-2F9D17518FA5Q34752713-C3FF13A1-D7DB-406B-AE9B-B9847A5AA35DQ35124719-D50FEC62-0CE6-4EBE-93CD-161D2C520580Q36110453-97658C8A-F4E0-4821-B122-6B05B948A69BQ36156022-26F98715-3EB6-46BA-81D4-B765F74F9941Q36894448-C6B8A2CB-3019-4FDF-B5C8-331C7F7BF92EQ36929388-4CE8B429-E9FB-475A-9C11-35B3704BA75AQ36982691-970C583F-790C-48F5-9D4F-8CB4B9898FA7Q37387773-97031F15-AF89-4164-8F84-B68C45E9BAC5Q39100187-B8CF2A92-D6E2-43E7-B671-B9690EB012D3Q40107036-E27EC6F7-BD59-4BAC-A2E4-4FE200499BD0Q41308701-C1FAB3EE-EBA4-4FC9-8F36-20695B7A91B2Q41452955-1FE85A09-43D0-4EB7-930A-7ABD7CF0D2DEQ41914956-2E77473E-FBDF-4128-9646-B749789CB383Q48275390-C8A49AE3-E743-4537-95F9-78C7BEA448E6Q48371616-EAD39374-6993-4F98-98A9-6E3B7FA3385B
P2860
Bolus fibrinolytic therapy in acute myocardial infarction.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Bolus fibrinolytic therapy in acute myocardial infarction.
@ast
Bolus fibrinolytic therapy in acute myocardial infarction.
@en
Bolus fibrinolytic therapy in acute myocardial infarction.
@nl
type
label
Bolus fibrinolytic therapy in acute myocardial infarction.
@ast
Bolus fibrinolytic therapy in acute myocardial infarction.
@en
Bolus fibrinolytic therapy in acute myocardial infarction.
@nl
prefLabel
Bolus fibrinolytic therapy in acute myocardial infarction.
@ast
Bolus fibrinolytic therapy in acute myocardial infarction.
@en
Bolus fibrinolytic therapy in acute myocardial infarction.
@nl
P2093
P356
P1476
Bolus fibrinolytic therapy in acute myocardial infarction.
@en
P2093
E M Antman
J Llevadot
R P Giugliano
P304
P356
10.1001/JAMA.286.4.442
P407
P577
2001-07-01T00:00:00Z